Neurostimulation Devices Market Analysis

End-user (Hospitals, Surgical Centers, Specialty Clinics)

The global neurostimulation devices market is segmented and analyzed for demand and supply by end-user into hospitals, ambulatory surgical centers, and specialty clinics. Out of these segments, the hospitals segment is anticipated to garner the largest market share over the forecast period, owing to the rising healthcare infrastructure globally, and the increasing incidence of chronic pain. As per the data, Indian healthcare infrastructure is projected to grow to USD 345 billion by the end of 2022. In addition, the growing number of hospitals globally is also expected to boost the growth of this segment in the coming years. For instance, there were approximately 6000 hospitals in the United States in 2020.

Product (Spinal Cord Stimulators, Deep Brain Stimulators, Cochlear Implants, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Percutaneous Tibial Nerve Stimulators, Transcranial Magnetic Stimulators)

The global neurostimulation devices market is also segmented and analyzed for demand and supply by product type into spinal cord stimulators, deep brain stimulators, cochlear implants, vagus nerve stimulators, sacral nerve stimulators, and transcranial magnetic stimulators. Out of these segments, by 2037 the spinal cord stimulation segment is anticipated to lead the market in terms of revenue. Some of the factors influencing the growth of this market include the rising prevalence of spinal cord injuries, chronic pain, the rising acceptance of SCS devices, and the attractive reimbursement environment for SCS treatments. As per data, more than 16,900 new cases of spinal cord injuries occur in the United States every year.

Our in-depth analysis of the global market includes the following segments: